"Based on a workshop of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine." Includes bibliographical references.

The role of research in countering bioterrorism / Anthony S. Fauci -- The political perspective of the bioterrorism threat / William Frist -- Update on the implications of anthrax bioterrorism / James M. Hughes -- Framing the issues / Edward M. Eitzen, Jr. -- Framing the debate: applying the lessons learned / Michael T. Osterholm -- Building capacity to prevent and respond to bioterrorism / Margaret A. Hamburg -- Bioterrorism: communicating an effective response / Scott R. Lillibridge -- Anthrax / Arthur M. Friedlander -- Medical countermeasures against the re-emergence of smallpox virus / Peter B. Jahrling -- Tularemia and plague: assessing our understanding of the threat / David T. Dennis -- Botulinum toxin as a bioweapon / Stephen S. Arnon -- Research considerations for better understanding of biological threats / Kenneth Alibek -- Aerosol technology and biological weapons / C.J. Peters, Richard Spertzel, William Patrick. Reducing the risk: foodborne pathogen and toxin diagnostics / Susan E. Maslanka, Jeremy Sobel, Bala Swaminathan. Vaccines for threatening agents: ensuring the availability of countermeasures for bioterrorism / Philip K. Russell -- The Department of Defense and the development and procurement of vaccines against dangerous pathogens: a role in the military and civilian sector? / Anna Johnson-Winegar -- Applications of modern technology to emerging infections and disease development: a case study of ebola virus / Gary J. Nabel -- Meeting the regulatory and product development challenges for vaccines and other biologics to address terrorism / Jesse L. Goodman -- Moving the vaccine agenda forward: obstacles and opportunities / Stanley Plotkin -- Countermeasures to biological threats: the challenges of drug development / Gail H. Cassell -- The FDA and the end of antibiotics / David M. Shlaes and Robert C. Moellering, Jr. -- The role of antivirals in responding to biological threats / C.J. Peters -- New research in antitoxins / R. John Collier. Recombinant human antibody: immediate immunity from botulinum neurotoxin and other class A biothreat agents / James D. Marks -- Meeting the regulatory and product development challenges to address terrorism / Andrea Meyeroff -- Regulation and production of recombinant human antibodies / Kathryn E. Stein -- Lessons being learned: the challenges and opportunities / Julie L. Gerberding -- The response infrastructure: investigating the anthrax attacks / Bradley Perkins -- The Centers for Disease Control bioterrorism investigation / Kevin Yeskey -- VA capability to enhance the medical response to a domestic biological threat / Kristi L. Koenig -- The progress, priorities, and concerns of public health laboratories / Mary J.R. Gilchrist -- The role of the centers for public health preparedness / Stephen S. Morse -- The role of coordinated information dissemination: the cascade system in the United Kingdom / John Simpson -- State and local needs for responding to bioterrorism / Michael S. Ascher. U.S. Public Health Service Office of Emergency Preparedness / Donald C. Wetter -- Assessing state and territorial health departments / James J. Gibson -- Countering bioterrorism threats: local public health perspectives / Thomas L. Milne -- Public health priorities for responding to bioterrorism / Ruth L. Berkelman -- Innovative surveillance methods for monitoring dangerous pathogens / Julie A. Pavlin [and others] -- The use of computational modeling in responding to biological threats / Donald S. Burke -- Diagnostics and detection methods: improving rapid response capabilities / David A. Relman -- National security and openness of scientific research / Ronald M. Atlas -- Coordinating the intelligence, public health, and research communities / Craig Watz -- Virtually assured detection and response: utilizing science, technology, and policy against bioterrorism / Scott P. Layne -- Research and the public health response / Eric Eisenstadt. And Assessment / Adel Mahmoud -- The Role of Research in Countering Bioterrorism / Anthony S. Fauci -- The Political Perspective of the Bioterrorism Threat / William Frist -- Update on the Implications of Anthrax Bioterrorism / James M. Hughes -- Framing the Issues / Edward M. Eitzen, Jr. -- Framing the Debate: Applying the Lessons Learned / Michael T. Osterholm -- Building Capacity to Prevent and Respond to Bioterrorism / Margaret A. Hamburg -- Bioterrorism: Communicating an Effective Response / Scott R. Lillibridge -- Anthrax / Arthur M. Friedlander -- Medical Countermeasures Against the Re-emergence of Smallpox Virus / Peter B. Jahrling -- Tularemia and Plague: Assessing Our Understanding of the Threat / David T. Dennis -- Botulinum Toxin as a Bioweapon / Stephen S. Arnon -- Research Considerations for Better Understanding of Biological Threats / Kenneth Alibek -- Aerosol Technology and Biological Weapons / C.J. Peters, Richard Spertzel and William Patrick -- Reducing the Risk: Foodborne Pathogen and Toxin Diagnostics / Susan E. Maslanka, Jeremy Sobel and Bala Swaminathan -- Vaccines for Threatening Agents: Ensuring the Availability of Countermeasures for Bioterrorism / Philip K. Russell -- The Department of Defense and the Development and Procurement of Vaccines Against Dangerous Pathogens: A Role in the Military and Civilian Sector? / Anna Johnson-Winegar -- Applications of Modern Technology to Emerging Infections and Disease Development: A Case Study of Ebola Virus / Gary J. Nabel -- Meeting the Regulatory and Product Development Challenges for Vaccines and Other Biologies to Address Terrorism / Jesse L. Goodman -- Moving the Vaccine Agenda Forward: Obstacles and Opportunities / Stanley Plotkin -- Countermeasures to Biological Threats: The Challenges of Drug Development / Gail H. Cassell -- The FDA and the End of Antibiotics / David M. Shlaes and Robert C. Moellering, Jr. -- The Role of Antivirals in Responding to Biological Threats / C.J. Peters -- New Research in Antitoxins / R. John Collier -- Recombinant Human Antibody: Immediate Immunity from Botulinum Neurotoxin and Other Class A Biothreat Agents / James D. Marks -- Meeting the Regulatory and Product Development Challenges to Address Terrorism / Andrea Meyeroff -- Regulation and Production of Recombinant Human Antibodies / Kathryn E. Stein -- Lessons Being Learned: The Challenges and Opportunities / Julie L. Gerberding -- The Response Infrastructure: Investigating the Anthrax Attacks / Bradley Perkins -- The Centers for Disease Control Bioterrorism Investigation / Kevin Yeskey -- VA Capability to Enhance the Medical Response to a Domestic Biological Threat / Kristi L. Koenig -- The Progress, Priorities, and Concerns of Public Health Laboratories / Mary J.R. Gilchrist -- The Role of the Centers for Public Health Preparedness / Stephen S. Morse -- The Role of Coordinated Information Dissemination: The Cascade System in the United Kingdom / John Simpson -- State and Local Needs for Responding to Bioterrorism / Michael S. Ascher -- U.S. Public Health Service Office of Emergency Preparedness / Donald C. Wetter -- Assessing State and Territorial Health Departments / James J. Gibson -- Countering Bioterrorism Threats: Local Public Health Perspectives / Thomas L. Milne -- Public Health Priorities for Responding to Bioterrorism / Ruth L. Berkelman -- Innovative Surveillance Methods for Monitoring Dangerous Pathogens / Julie A. Pavlin, Patrick Kelley and Farzad Mostashari, et al -- The Use of Computational Modeling in Responding to Biological Threats / Donald S. Burke -- Diagnostics and Detection Methods: Improving Rapid Response Capabilities / David A. Relman -- National Security and Openness of Scientific Research / Ronald M. Atlas -- Coordinating the Intelligence, Public Health, and Research Communities / Craig Watz -- Virtually Assured Detection and Response: Utilizing Science, Technology, and Policy Against Bioterrorism / Scott P. Layne -- Research and the Public Health Response / Eric Eisenstadt -- App. Agenda: Biological Threats and Terrorism: How Prepared Are We? Assessing the Science and Our Response Capabilities -- App. Testimony of Joshua Lederberg, Ph. D. -- App. Summary of the Frist-Kennedy "Bioterrorism Preparedness Act of 2001"--App. Department of Health and Human Services: Food and Drug Administration [Docket No. 01N-0494] -- App. Veterans Affairs/Department of Defense Contingency -- App. The Model State Emergency Health Powers Act -- App. NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness -- App. Statement on Vaccine Development -- App. Testimony of Kenneth I. Shine, M.D. -- App. Glossary and Acronyms -- App. Forum Member, Speaker, and Staff Biographies.